Advertisement
UK markets close in 3 hours 13 minutes
  • FTSE 100

    8,337.71
    +24.04 (+0.29%)
     
  • FTSE 250

    20,407.44
    -5.64 (-0.03%)
     
  • AIM

    777.59
    +1.17 (+0.15%)
     
  • GBP/EUR

    1.1615
    -0.0009 (-0.08%)
     
  • GBP/USD

    1.2478
    -0.0032 (-0.25%)
     
  • Bitcoin GBP

    50,000.04
    -989.52 (-1.94%)
     
  • CMC Crypto 200

    1,320.67
    +26.00 (+2.01%)
     
  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     
  • DOW

    38,884.26
    +31.99 (+0.08%)
     
  • CRUDE OIL

    77.36
    -1.02 (-1.30%)
     
  • GOLD FUTURES

    2,325.10
    +0.90 (+0.04%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • DAX

    18,487.38
    +57.33 (+0.31%)
     
  • CAC 40

    8,142.88
    +67.20 (+0.83%)
     

Allstate (ALL) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended March 2023, Allstate (ALL) reported revenue of $13.77 billion, up 9.3% over the same period last year. EPS came in at -$1.30, compared to $2.58 in the year-ago quarter.

The reported revenue represents a surprise of +7.38% over the Zacks Consensus Estimate of $12.83 billion. With the consensus EPS estimate being -$1.94, the EPS surprise was +32.99%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Allstate performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Property-liability - Combined ratio: 108.6% versus 103.5% estimated by seven analysts on average.

  • Property-liability - Loss ratio: 87.5% versus 79.85% estimated by six analysts on average.

  • Property-liability - Expense ratio: 21.1% versus 22.48% estimated by six analysts on average.

  • Allstate Health and Benefits Segment- Net Investment Income: $19 million compared to the $17.52 million average estimate based on eight analysts.

  • Revenues- Accident and health insurance premiums and contract charges: $463 million compared to the $460.20 million average estimate based on eight analysts.

  • Property-Liability- Net Premiums Earned: $11.64 billion versus $11.51 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +10.8% change.

  • Property-liability- Other Revenue: $353 million versus $355.82 million estimated by six analysts on average.

  • Corporate and Other- Net Investment Income: $31 million compared to the $20.39 million average estimate based on five analysts.

  • Protection Services- Net Premiums Earned: $538 million compared to the $565.97 million average estimate based on four analysts.

  • Property-Liability- Net Investment Income: $509 million versus $522.64 million estimated by four analysts on average.

  • Allstate Health and Benefits Segment- Other Revenue: $101 million versus $102.53 million estimated by four analysts on average.

  • Revenues- Net investment income: $575 million versus the four-analyst average estimate of $597.88 million. The reported number represents a year-over-year change of -3.2%.

View all Key Company Metrics for Allstate here>>>

Shares of Allstate have returned -0.7% over the past month versus the Zacks S&P 500 composite's +0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Allstate Corporation (ALL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research